510(k) Report

510(k) · Cleared

Cleared

gel-e Flex

K180152510(k) TraditionalCleared Jun 22, 2018154-day reviewClass U

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Gel-E, Inc. · QSY Hemostatic Wound Dressing Without Thrombin Or Other Biologics

Cleared on Jun 22, 2018 as substantially equivalent to K072486 (Hem Con Medical Technologies, Inc., 2008) after a 154-day review. Its family tree reaches back 5 generations to 1997. 2 later devices descend from it.

Decided
Jun 22, 2018
Review
154 days
Class
Class U
Product code
QSY
Recalls
None
Predicates
1

Its longest line of descent runs back 5 generations to K972914 (1997). 7 ancestors in all. 2 later devices descend from it, 1 citing it directly.

  1. Root · 5 generations backK972914 Syvek PatchMarine Polymer Technologies, Inc. · 1997
  2. 4 generations backK023298 Hemcon BandageHemcon, Inc. · 2002
  3. 3 generations backK030946 Hemcon Bandage Otc; Hemcon Cath/AidHemcon, Inc. · 2003
  4. 2 generations backK043050 Hemcon Bandage and Hemcon Bandage OtcHemcon, Inc. · 2005
  5. 1 generation backK072486 Modification to Hemcon Bandage and Hemcon Bandage OtcHem Con Medical Technologies, Inc. · 2008 · Recalled
  6. This deviceK180152 gel-e FlexGel-E, Inc. · 2018
  7. Descendant · cites it directly · 1 of its ownK213652 Cresilon Hemostatic Gel, CHG, Cresilon Hemostatic Gel (CHG)Cresilon, Inc. · 2023
  8. Descendant · 2 generations on · 0 of its ownK253609 TRAUMAGEL® 2.0 Hemostatic GelCresilon, Inc. · 2025

Most influential descendants

Showing 2 of 2 · See all
  • K213652Cresilon Hemostatic Gel, CHG, Cresilon Hemostatic Gel (CHG)Cresilon, Inc. · 2023 · cites it directly1descendant
  • K253609TRAUMAGEL® 2.0 Hemostatic GelCresilon, Inc. · 2025 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−5K972914Syvek PatchMarine Polymer Technologies, Inc.1997—
−4K023298Hemcon BandageHemcon, Inc.2002—
−3K030946Hemcon Bandage Otc; Hemcon Cath/AidHemcon, Inc.2003—
−2K043050Hemcon Bandage and Hemcon Bandage OtcHemcon, Inc.2005—
−1K072486Modification to Hemcon Bandage and Hemcon Bandage OtcHem Con Medical Technologies, Inc.20086
0 (this device)K180152gel-e FlexGel-E, Inc.2018—
+1K213652Cresilon Hemostatic Gel, CHG, Cresilon Hemostatic Gel (CHG)Cresilon, Inc.2023—
+2K253609TRAUMAGEL® 2.0 Hemostatic GelCresilon, Inc.2025—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199810
200010

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202310
202510
FIG. 1 — Lineage of K180152, 1997–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in QSY? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new QSY device

  1. #1 K240713 Traumagel®score 15.1 · 5 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K072486Modification to Hemcon Bandage and Hemcon Bandage Otc
Summary page 5
…314-9592 Jan 17,2018 gel-e Flex Dressing, Wound, Drug Unclassified Device (pre-amendment) Unclassified FRO Hemcon Medical Technologies’ Hemcon Bandage OTC Dressing (K072486) Hemcon Medical Technologies’ GuardaGel (K112215) gel-e’s Gel-e Bandage (K172010) Over-The-Counter Use (21 CFR 801 Subpart C):…
Hem Con Medical Technologies, Inc.20086
†K112215Hemcon Hemostatic GelHemcon Medical Technologies Europe, Ltd.2012—
†K172010gel-e BandageGel-E, Inc. (Formerly Remedium Technologies, Inc.)2017—

Also cleared against K072486: 3 other devices →

What descends from it? (2)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K213652Cresilon Hemostatic Gel, CHG, Cresilon Hemostatic Gel (CHG)Cresilon, Inc.20231

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 21 years and passes through 4 companies; a new generation was cleared every 3.2 years on median.
  • 1 of the 7 ancestors has a recall of any class.
  • Of its descendants, K213652 (Cresilon, Inc., 2023) has gone furthest, with 1 descendant of its own.
  • 3 other devices also cite its predicate K072486.

How does its category compare?

All QSY devices

QSY Hemostatic Wound Dressing Without Thrombin Or Other Biologics: FDA decisions, review times, recalls and adverse event reports over 20 years. 2018, this device’s year, is highlighted.

FDA decisions per year · QSY

2in 2025

2007: 132008: 72009: 92010: 72011: 82012: 72013: 32014: 62015: 62016: 52017: 12018: 52019: 42020: 12021: 12022: 22023: 72024: 42025: 22026 (partial year): 2
2007high 13 (2007) · low 1 (2017)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · QSY

142in 2024

2007: 63 days median2008: 61 days median2009: 55 days median2010: 75 days median2011: 137 days median2012: 239 days median2013: 161 days median2014: 249 days median2015: 171 days median2016: 161 days median2018: 186 days median2019: 336 days median2023: 586 days median2024: 142 days median
2007high 586 (2023) · low 55 (2009)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · QSY

No recall names QSY since 2007.

Adverse event reports per year · QSY

14in 2025

2022: 12024: 32025: 14
2007high 14 (2025) · low 0 (2007)2025

MAUDE reports naming product code QSY, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007136300
200876100
200995500
201077500
2011813700
2012723900
2013316100
2014624900
2015617100
2016516100
20171—00
2018518600
2019433600
20201—00
20211—00
20222—01
2023758600
2024414203
20252—014
20262—0—

What is it indicated for?

gel-e Flex is indicated for the local management of bleeding such as laceration and minor bleeding.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K180152: gel-e Flex.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K180152

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026